Atherosclerosis is a multifactorial disease in which hypertension, diabetes, hyperlipidemia and other risk factors are thought to play a role. However, the molecular processes underlying plaque formation and progression are not yet completely known. In the last years some researchers applied proteomics technologies for the comprehension of biochemical pathways of atherogenesis and to search new cardiovascular biomarkers to be utilized either as early diagnostic traits or as targets for new drug therapies. Due to its intrinsic complexity, the problem has been approached by different strategies, all of which have some limitations. In this review, we summarize the most common critical experimental variables in two-dimensional electrophoresis-based techniques and recent data obtained by applying proteomic approaches in the study of atherosclerosis.
Introduction
Atherosclerosis is a form of chronic inflammation characterized by the accumulation of lipids and fibrous elements in medium and large arteries. Oxidation of low density lipoproteins (LDL, Lp (a)) infiltered into the subendothelial space induces migration of circulating monocytes and their differentiation into macrophages. Uptake of a large amount of ox-LDL by macrophages leads to foam cell formation and necrosis. Cytokines secreted by T-limphocytes and foam cells attract smooth muscle cells that migrate from the medial portion of the artery, proliferate and secrete new extracellular matrix forming a fibrous cap surrounding the necrotic core. The stability of advanced atherosclerotic lesions may be influenced by the degree of inflammation, extracellular matrix degradation, calcification and neovascularization 1 . The rupture of the atherosclerotic plaque is the predominant underlying process in the pathogenesis of acute coronary syndromes and peripheral vascular disease 2 . Disease etiology is very complex and includes several important environmental and genetic risk factors such as hyperlipidemia, diabetes, and hypertension. Knowledge of the molecular mechanisms underlying this pathology is nowadays a challenge. In this regard, in the last years some researchers have approached these issues by means of proteomics to individuate both
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eJIFCC2008Vol19No3pp146-159 pathways of atherosclerotic process and possible circulating markers for prevention and early diagnosis 3 . Proteomics technologies allow one to evaluate simultaneously patterns and expression levels of hundreds or even thousands proteins, also identifying differentially expressed proteins and post-translational modifications 4 . The technology of choice for these purposes is high-resolution two-dimensional electrophoresis (2-DE) that enables the separation of proteins in the first dimension in relation to their intrinsic charge (isoelectric point) and then, orthogonally, according to their relative mass (Mr) 5, 6 .
The analyses of the entire proteomes are limited by the high dynamic range of protein abundance in different samples and their heterogeneity with respect to Mr, pI, and hydrophobicity. Cellular proteins range from 10 5 -10 6 copies/cell for housekeeping proteins to <10 2 copies/cell for receptor molecules with a total of up to 10000 different proteins in eukaryotic cell extracts. Plasma is composed for 90% by only 9 proteins (albumin, IgG, transferrin, haptoglobin etc.), others 12
proteins represent another 9% of total and the remaining 1% is constituted by about 50000 low expressed protein variants called "deep proteome". Plasma protein levels range from 40-50mg/ml for albumin to <10ng/ml for interleukins, chatepsins and peptide hormones. Tissue proteomics is also complicated by the large heterogeneity of cellular components. In this respect, although several standard protocols have been developed, sample preparation for subsequent proteomic analysis must be adapted and optimized in relation to the specimen under study. Due to the high complexity of different proteomes often researchers focalize on specific sub-proteomes by analysing subcellular components (such as organelles or membranes), enriched plasma fractions (immunosubtraction of more abundant proteins), or tissue microdissections 7 .
Sample preparation for 2D analysis
Many different procedures for cell lysis and protein extraction could be performed, individually or in combination, according to specific objectives. Hard procedures include freeze-thawing of sample, detergent lysis, sonication and homogenization. Soft procedures are based on enzymatic or osmotic lysis, also useful to obtain intact subcellular fractions. Some substances could interfere with subsequent 2D analysis and must be inactivated or removed. First, proteolytic enzymes present in all specimens must be inactivated, usually by adding a cocktail of protease inhibitors and/or lowering the pH, or denaturated by boiling the sample in SDS containing buffers. Salts are interfering compounds for the isoelectric focusing at concentrations >100mM. Dialysis, gel filtration and protein precipitation with TCA are the most common methods for salt removal. Also nucleic acids and polysaccharides, if presents at interfering concentrations, must be removed since they could give rise to streaky 2D patterns. Protein precipitation with TCA/acetone, treatment with
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Then, extracted proteins, free of interfering compounds, must be resolubilised in a denaturating buffer containing a chaotrope (7-9 mol/L urea in combination with 2 mol/L thiourea for hydrophobic proteins), zwitterionic or non-ionic detergents (CHAPS, sulfobetaines, Triton-X100
and NP-40 ranging from 1 to 4%) and a reducing agent (DTT, DTE, TBP, TCEP ranging from 2 to 100 mmol/L) for complete disruption of inter-and intra-molecular interactions. Sometimes protease inhibitors are also added to solubilisation buffer. Urea, in aqueous solutions is in equilibrium with ammonium cyanate that can react with protein amino groups so introducing charge artefacts. So, it would be better to avoid heating urea containing solutions over 37 °C. Also temperatures lower than 10 °C must be avoided (urea crystallization). Optimal working temperature is approximately 20 °C.
By using all these pre-treatments, extracted proteins result free of interfering compounds and completely unfolded, although maintaining their intrinsic charge.
2D electrophoresis
The most widely used approach for evaluate protein patterns and expression levels is based on the method described by O'Farrell, that allowed to resolve more than 1000 different protein spots from
Escherichia coli by an isoelectric focusing separation based on intrinsic charge of each protein isoform and subsequently an SDS-PAGE orthogonally conducted 8 . Due to the instability of pH gradients generated by pre-focusing polyamino-polycarboxylic acids (carrier ampholytes), especially at basic pH, the method evolved following the introduction of immobilized pH gradient strips (IPG strips), in which pH gradients are generated by copolymerizing, together with acrylamide, ten derivatives containing either a carboxyl or an amino group. This allowed to obtain extremely stable pH gradients over the range 1-13 with a greatest resolution of 0.001 pH units.
Sample loading could be carried out by active or passive rehydration of dried strips or by cuploading. Then proteins are resolved under high voltages in function of their isoelectric point. After focusing two steps of equilibration are needed: first, strips are incubated in a Tris buffer containing 6 mol/L urea, 30% glycerol, and 3% SDS with the addition of 1% DTT, followed by an equilibration in the same buffer without DTT, but with the addition of 2.5% iodoacetamide. These treatments allow to completely solubilise proteins eventually precipitated at their pI, to give a uniform negative charge density to the proteins, because of the anionic detergent SDS, and to reduce and alkylate any protein sulfydryl groups. Proteins are then resolved by SDS-PAGE as spots in function of their M r and visualized by gel staining. In this respect many procedures are described:
Coomassie brillant blue and silver staining, fluorescent dyes, or autoradiography for radioactively labelled proteins, and some others. All these procedures have one or more limitations in relation to 
Spot identification
Spots of interest, e.g. differentially expressed or variably modified, could be identified and characterized by means of mass spectrometry analysis. These instruments can perform highly accurate mass measurements and sequencing of peptides ranging from 1000 to 4000 amu (atomic mass unit). Behind this technology there is the high specificity of certain proteolytic enzymes or chemicals to cleave the proteins at specific sites. For example, trypsin the most widely used enzyme cleaves peptide chains at the carboxyl side of the amino acids lysine and arginine, except when they are followed by proline, so producing a pattern of peptides characteristics for every protein (Peptide Mass Fingerprinting). First, proteins must be excised from the gel (stained with a mass compatible protocol) by a scalpel or a sterile tip, destained, dehydrated and air dried. Subsequently, spots are reswollen with a solution containing a sequencing grade modified trypsin resistant to autoproteolysis and incubated over night at 37°C (in-gel digestion). Peptides are then extracted from the gel and analysed by mass spectrometry [ figure 1 ].
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In short, the mass spectrometer (MALDI-TOF MS, ESI MS/MS) converts, in the source, Page 150
The resulting mass spectra could be compared, by means of specific softwares, free on web (e.g. 
Aims of proteomics
A proteome is the entire protein content expressed by a genome. However, it is something of an abstraction because, in the same organism, it is dependent on the time, the cellular type, and the physio-pathological conditions. It includes all splicing variants and isoforms from post-translational modifications. Proteome of cell cultures also reflects the experimental conditions adopted.
The purpose of proteome mining is to identify as many components of the proteome as possible to Table 1 ]. Some proteomic studies on homogenates of human atherosclerotic plaques have been reported. You et al. 28 , by analyzing 10 diseased (stenosed by 80% to 100%) and 7 normal autoptic coronary arteries reported an about 2 fold increase of the ferritin light chain in the pathological specimens.
Either pro-oxidant or anti-oxidant roles for this protein in atherosclerosis have been suggested.
However, according to the "iron hypothesis", the authors speculated that this increase may contribute to the pathogenesis of coronary artery disease by modulating oxidation of lipids within the vessel wall through the generation of reactive oxygen species.
Donners et al. 29 analyzed 5 stable plaques and 6 lesions with a thrombus from patients undergoing endarterectomy, classified according to Virmani et al. 27 , so revealing, in advanced plaques, the expression of six isoforms of the acute phase protein α1-antitrypsin, one of which was uniquely expressed in thrombus-containing plaques. Recently, Sung et al. 30 analyzed atherosclerotic specimens from 7 patients undergoing aorta bypass surgery and biopsies of the normal aorta tissues from the same patients, as controls. They identified a panel of 27 proteins differentially expressed in the atherosclerotic aorta compared with the normal aorta involved in a number of biological processes, including calcium-mediated processes, migration of vascular smooth muscle cells, matrix metalloproteinase activation and regulation of pro-inflammatory cytokines.
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A different approach was adopted by Martin-Ventura et al. 31, 32 that analyzed the protein secretion profiles obtained from 35 cultured atherosclerotic plaques and 36 control arteries (24 mammary, 12 radial) in the search of new biological markers potentially released by the arterial wall into the plasma. In particular, they isolated and analyzed in parallel non-complicated and ruptured/thrombosed areas of the carotid plaques. Plaque and control samples were cut in small fragments and incubated in protein-free culture medium during 24 h at 37°C. Proteins secreted in the supernatants were then resolved by 2D electrophoresis and differential image analysis was carried out. They showed that heat shock protein 27 secretion into the culture medium was significantly lower in atherosclerotic plaques than in control arteries, and confirmed the finding by Western blotting analysis. They also evidenced a 20-fold reduction in HSP27 levels in the plasma of patients with carotid stenosis respect to healthy controls so identifying HSP27 as a possible marker of atherosclerosis.
The same research group evaluated the effects of incubation with atorvastatin on the secretomes of cultured atherosclerotic plaques 33 . They identified 24 proteins that were increased and 20 proteins that were decreased in atheroma plaque supernatants compared to controls. Interestingly, the presence of atorvastatin in culture medium reverted secretion of 66% proteins to control values. In this report, authors identified Cathepsin D as a potential target for therapeutical treatment of atherosclerosis.
Recently, we evaluated differential protein expression in 48 immunohistochemical classified stable and unstable plaques obtained from carotid endarterectomy 34 . We analyzed, by a sub-proteomic approach, extracts from finely minced tissues in order to permit an enrichment in both topically expressed and filtered/retained proteins in attempting to simplify an otherwise very complex two dimensional protein pattern. A total of 57 distinct spots corresponding to 33 different proteins were identified in both stable and unstable plaques by peptide mass fingerprinting, most of which were of plasma origin (about 70%). This suggests the existence of an impaired endothelial barrier function independent of plaque type. Compared to stable plaques, unstable ones showed reduced abundance of protective enzymes superoxide dismutase 3 (SOD3) and glutathione s-transferase (GST), small heat shock proteins HSP27 and HSP20, annexin A10, and Rho GDP-dissociation inhibitor and an higher abundance of ferritin light subunit, superoxide dismutase 2 (SOD2) and β-fibrinogen fragment D. These proteins are described to play a role in either oxidative or inflammatory processes and in the formation and progression of the atherosclerotic plaques. The limitation of our findings rests on the fact that we studied the whole plaques that are known to be structurally heterogeneous. In this respect, it should be noticed that, in a single lesion, a variable degree of
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histological heterogeneity is present so probably accounting for different gene and protein expression between diverse plaque areas.
Future directions in the study of atherosclerotic plaques by proteomic approaches could be the analysis of laser captured microdissections and the evaluation of protein post-translational modifications, in particular oxidative modifications, in the search of specific biochemical pathways or new markers for diagnostic, prognostic, and therapeutic purposes. Figure 1 . Processing of protein spots by peptide mass fingerprinting. 
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